aprepitant
Generic: aprepitant
Labeler: sandoz incDrug Facts
Product Profile
Brand Name
aprepitant
Generic Name
aprepitant
Labeler
sandoz inc
Dosage Form
CAPSULE
Routes
Active Ingredients
aprepitant 125 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0781-2323
Product ID
0781-2323_a194823e-5961-4bc0-b18f-2f63d3cbb9c6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090999
Listing Expiration
2026-12-31
Marketing Start
2016-12-27
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
07812323
Hyphenated Format
0781-2323
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
aprepitant (source: ndc)
Generic Name
aprepitant (source: ndc)
Application Number
ANDA090999 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 125 mg/1
Packaging
- 1 BLISTER PACK in 1 CARTON (0781-2323-68) / 6 CAPSULE in 1 BLISTER PACK (0781-2323-06)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a194823e-5961-4bc0-b18f-2f63d3cbb9c6", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "644088", "754508"], "spl_set_id": ["f58b8944-93ee-4be1-a238-cc0061ddd93a"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (0781-2323-68) / 6 CAPSULE in 1 BLISTER PACK (0781-2323-06)", "package_ndc": "0781-2323-68", "marketing_start_date": "20161227"}], "brand_name": "Aprepitant", "product_id": "0781-2323_a194823e-5961-4bc0-b18f-2f63d3cbb9c6", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0781-2323", "generic_name": "aprepitant", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aprepitant", "active_ingredients": [{"name": "APREPITANT", "strength": "125 mg/1"}], "application_number": "ANDA090999", "marketing_category": "ANDA", "marketing_start_date": "20161227", "listing_expiration_date": "20261231"}